- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 28.6M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $31.03M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $8.64M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $9.68M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $7.28M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $50.14M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $47.36M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $36.26M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $11.76M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $60.36M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $35.08M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 8.26M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $24K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$3.83M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $11.59M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $20.47M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$1.13 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$1.13 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $2.67M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $2.31M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$9.13M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$9.27M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $45K |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $109K |
| Revenue | Q1 2025 · Mar 31, 2024 | $176K |